8 Jun 2017 SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) (the "Company" or represents a premium of 11% over SciClone's closing stock price on Unlike A shares, U.S. stocks do not have daily share price limit up or limit down. This may mean heightened risks, which investors should be aware of. 4. Day trade Certain web sites, such as Yahoo, add an extension to symbols for over-the- counter bulletin board stocks (.OB) and pink sheet stocks (.PS). In the following list, AGN Price Forecast Based on Dividend Discount Model fair share price based primarily on the dividend the stock provides relative to a number of other quantiative aspects of its business. 39, SCLN · SciClone Pharmaceuticals, Inc. 0.00%. 30 Mar 2012 Buying stocks on the cheap can be a tricky gambit, as there is usually a reason why the price is so low. In some cases, however, the reason 17 Dec 2010 3 Breakout Stocks Under $5 Biotech stocks are on the rise right now for many but my screens still rate SCLN stock strongly because of big buying But with an average Wall Street price target of $8 and a high target of $10, 31 Mar 2018 The bands encapsulate the price movement of a stock. It provides relative Did I fail to mention this is a 5-minute chart of SCLN? If you had just
been a lot of studies by stock market professionals on the price charts  , and around 20 ROIAK SCHN SCLN SCZ SFLY SHOO SLGN SMRT SPLS.
SCLN | SciClone Pharmaceuticals Inc | Dividend History ... SCLN Dividend History & Description — SciClone Pharmaceuticals Inc. SciClone Pharmaceuticals is a pharmaceutical company with a product portfolio of therapies for oncology, infectious diseases and cardiovascular disorders. Co.'s business is focused primarily on the People's Republic of China. Insider Trading activities of Sciclone Pharmaceuticals Inc ... Insider trading activities including stock purchases, stock sales, and option exercises of SCLN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Sciclone Pharmaceuticals Inc (symbol SCLN, CIK number 880771) see the Securities and Exchange Commission (SEC) website. SciClone Enters Into Definitive Merger Agreement To Be ... SciClone Enters Into Definitive Merger Agreement To Be Acquired By Consortium Led By GL Capital SciClone to be acquired for $11.18 per share, representing a valuation of approximately $605 million
218200 (SCLN) Stock Historical Prices & Data - Yahoo Finance
During market hours, the real-time Cboe BZX price displays and new trade updates are updated on the page (as indicated by a "flash"). Volume always reflects consolidated markets. If the symbol has pre-market or post-market trades, that information will also be reflected along with the last (closing) price from the symbol's exchange.
stock market, and your investments. Investment Advice for SCLN Fundamental Analysis Technical Analysis Trend Tracker Special Offer Our Stock of the Week Strategy was beating the market by 225% as of Sep 2014. That is because it has integrated risk controls. We will show you how it is done. Stock Traders Daily also has the most accurate leading
Through its promotion business with pharmaceutical partners, SciClone also markets multiple branded products in China which are therapeutically differentiated. SciClone is a publicly-held corporation based in Foster City, California, and trades on the NASDAQ Global Select Market under the symbol SCLN. Sciclone Share Chart - SCLN | ADVFN
SCICLONE PHARMACEUTICALS, INC. : Stock Market News and ...
$SCLN (SciClone Pharmaceuticals, Inc.) Stream, Posts ... Article / Pick Mentions No recent mentions of SCLN in Stock Articles. No recent mentions of SCLN in Stock Picks. ↻ Update SCLN Symbol Stream
Lookup the fund or stock ticker symbol for any company on any exchange in any country at Marketwatch.